title: [Locally advanced and recurrent pelvic colorectal carcinoma: results of aggressive surgical treatment].
abstract: Pelvic exenteration has been described as a formidable procedure in cases of advanced or recurrent pelvic cancers for a variety of primary tumors, including colorectal, gynaecologic and urologic. We report our 14-year experience in a community hospital with 37 cases who underwent pelvic exenteration for recurrent (n = 15) or locally advanced (n = 22) colorectal cancers. At a median follow-up of 36 months, the median survival was 24 and 36 months, respectively, and the 5-year actuarial survival was 18% and 44%.
authors.affiliation: Ospedale MG Vannini, UOC di Chirurgia Generale e Oncologica, Roma.
authors.forename: C E
authors.initials: CE
authors.lastname: Vitelli
authors.forename: L
authors.initials: L
authors.lastname: Fortunato
authors.forename: F
authors.initials: F
authors.lastname: Crenca
authors.forename: A
authors.initials: A
authors.lastname: Di Nardo
authors.forename: G
authors.initials: G
authors.lastname: Zarrelli
authors.forename: M
authors.initials: M
authors.lastname: Farina
authors.forename: S
authors.initials: S
authors.lastname: Bianca
mesh_terms: D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000601:surgery*; D013505:Digestive System Surgical Procedures / Q000379:methods; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000601:surgery*